-
Product Insights
Net Present Value Model: Barhemsys
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Barhemsys Drug Details Amisulpride (APD-421, ACA-1421,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – amisulpride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry amisulpride Drug Details Amisulpride (APD-421, ACA-1421, Barhemsys) is a benzamide derivative. It is formulated...
-
Thematic Analysis
United States of America (USA) Drug Pricing and Reimbursement Landscape – Thematic Research
The US was already grappling with spiraling healthcare expenditure, lack of affordable care, astronomical drug prices, and a high number of uninsured individuals before the devastating COVID-19 pandemic hit, leaving the healthcare system decimated. Later in the year, the US presidential election added another layer of complexity and division, with the candidates battling over many healthcare issues.
-
Sector Analysis
Personal Accident and Health Insurance in Luxembourg, Key Trends and Opportunities to 2019
This report provides in-depth market analysis, information and insights into the Luxembourg personal accident and health insurance segment, including a detailed analysis of the key categories, along with market forecasts until 2019. In addition to exhaustive coverage of key performance indicators, there is also a detailed analysis of regulatory policies affecting participants in the Luxembourg insurance industry.
-
Sector Analysis
Non-Life Insurance in Luxembourg, Key Trends and Opportunities to 2019
This report provides in-depth market analysis and insights into the Luxembourg non-life insurance segment, including the non-life insurance segment’s growth prospects by non-life insurance category. In addition to detail of new products launched by Luxembourg’s non-life insurers, the report also contain historical values and projected figures up to 2019. Furthermore, there is analysis of the key developments in the segment.